The Record

The Orders Library

Name: The COVID Project Orders Library
Creator: The COVID Project

13,511 instruments indexed by The COVID Project: the orders of the fifty States and the District, forty metros, the federal layer and the agencies; the standing duties; the organizers' notices; the legal authorities. Filter by kind, State, limitation type, quarter and more; open the exhibit; download what you find.

Double quotes make a phrase ("stay at home"). An exhibit ID (TX-004) opens its record first.

The COVID Projectcovidproject.com/library

Filters:Agency cluster: Other federal health agencies Supply chain Business closure Clear all

28 instruments · showing 1–25

Sort Per page

Exhibit	Instrument	Issuer	Jurisdiction	Issued	Quarters	Limitations	Grade
Ex. AGY-FED-HEALTH-OTHER-038	Determination of Public Health Emergency and Declaration that circumstances exist justifying emergency use of in vitro diagnostics, 85 Fed. Reg. 7316 (Feb. 7, 2020)Determination of Public Health Emergency	Alex M. Azar II, Secretary of Health and Human Services	United States (federal); Department of Health and Human Services, Office of the SecretaryFederal	Feb. 4, 2020	2020 Q22020 Q32020 Q42021 Q12021 Q22021 Q3	Emergency declarationSupply chain	Primary source read
Ex. AGY-FED-HEALTH-OTHER-039	Emergency Use Declaration (personal respiratory protective devices), 85 Fed. Reg. 13907 (Mar. 10, 2020)Emergency Use Declaration	Alex M. Azar II, Secretary of Health and Human Services	United States (federal); Department of Health and Human Services, Office of the SecretaryFederal	Mar. 2, 2020	2020 Q22020 Q32020 Q42021 Q12021 Q22021 Q3	Emergency declarationSupply chain	Primary source read
Ex. AGY-FED-HEALTH-OTHER-052	Emergency Use Authorization: NIOSH-approved air purifying respirators for health care personnel (issued Mar. 2, 2020; reissued Mar. 28, 2020 and July 12, 2021)Letter of Authorization to CDC, NIOSH-Approved Air Purifying Respirators (reissued July 12, 2021)	Jacqueline A. O'Shaughnessy, Acting Chief Scientist, FDA (letter to CDC)	United States (federal); Food and Drug AdministrationFederal	July 12, 2021	2020 Q22020 Q32020 Q42021 Q12021 Q22021 Q3	Health care ordersSupply chain	Primary source read
Ex. AGY-FED-HEALTH-OTHER-072	Federal Bureau of Prisons COVID-19 Action Plan, Phase Two: agency-wide modified operations (Mar. 13, 2020)Federal Bureau of Prisons COVID-19 Action Plan: Agency-wide Modified Operations	Federal Bureau of Prisons (Director), after coordination with DOJ and the White House	United States (federal); Federal Bureau of PrisonsFederal	Mar. 13, 2020	2020 Q2	Business closureGathering capTravel and quarantineWorkplace rules	Primary source read
Ex. AGY-FED-HEALTH-OTHER-086	Press release of Mar. 16, 2020: 'Effective March 17, 2020, Social Security Offices Will Only Offer Phone Service'Effective March 17, 2020, Social Security Offices Will Only Offer Phone Service Online Services Remain Available	Social Security Administration (Andrew Saul, Commissioner; press release by Mark Hinkle, Acting Press Officer)	United States (federal); Social Security AdministrationFederal	Mar. 16, 2020	2020 Q22020 Q32020 Q42021 Q12021 Q22021 Q3	Context (guidance or announcement)Business closureTelework mandateCourts and public offices	Primary source read
Ex. AGY-FED-HEALTH-OTHER-041	Guidance for Industry: Temporary Policy for Preparation of Certain Alcohol-Based Hand Sanitizer Products During the Public Health Emergency (COVID-19) (Mar. 19, 2020; updated Mar. 27 and Apr. 15, 2020, and later)Temporary Policy for Preparation of Certain Alcohol-Based Hand Sanitizer Products During the Public Health Emergency (COVID-19)	Food and Drug Administration, CDER	United States (federal); Food and Drug Administration, Center for Drug Evaluation and ResearchFederal	Mar. 19, 2020	2020 Q22020 Q32020 Q42021 Q12021 Q22021 Q3	Context (guidance or announcement)Supply chainOther	Primary source read
Ex. AGY-FED-HEALTH-OTHER-012	DEA-DC-019 (DEA066), letter granting an exception permitting transmission of DEA Form 222 by fax or scan during the COVID-19 emergencyFax/Scan 222 (final) Esign	Thomas W. Prevoznik, Deputy Assistant Administrator, Diversion Control Division, DEA (letter to the Healthcare Distribution Alliance)	United States (federal); Drug Enforcement Administration, Diversion Control DivisionFederal	Mar. 20, 2020	2020 Q22020 Q32020 Q42021 Q12021 Q22021 Q3	Supply chainOther	Primary source read
Ex. AGY-FED-HEALTH-OTHER-043	Guidance for Industry and FDA Staff: Enforcement Policy for Ventilators and Accessories and Other Respiratory Devices During the Coronavirus Disease 2019 (COVID-19) Public Health Emergency (March 2020)Enforcement Policy for Ventilators and Accessories and Other Respiratory Devices During the Coronavirus Disease 2019 (COVID-19) Public…	Food and Drug Administration, CDRH	United States (federal); Food and Drug Administration, Center for Devices and Radiological HealthFederal	Mar. 22, 2020	2020 Q22020 Q32020 Q42021 Q12021 Q22021 Q3	Context (guidance or announcement)Health care ordersSupply chainOther	Primary source read
Ex. AGY-FED-HEALTH-OTHER-036	Emergency Use Authorization Declaration (medical devices, including alternative products used as medical devices), 85 Fed. Reg. 17335 (Mar. 27, 2020)Emergency Use Authorization Declaration	Alex M. Azar II, Secretary of Health and Human Services	United States (federal); Department of Health and Human Services, Office of the SecretaryFederal	Mar. 24, 2020	2020 Q22020 Q32020 Q42021 Q12021 Q22021 Q3	Emergency declarationSupply chain	Primary source read
Ex. AGY-FED-HEALTH-OTHER-042	Guidance for Industry: Temporary Policy for Manufacture of Alcohol for Incorporation Into Alcohol-Based Hand Sanitizer Products During the Public Health Emergency (COVID-19) (Mar. 24, 2020; updated Mar. 27 and Apr. 15, 2020, and later)Temporary Policy for Manufacture of Alcohol for Incorporation Into Alcohol-Based Hand Sanitizer Products During the Public Health Emergency…	Food and Drug Administration, CDER	United States (federal); Food and Drug Administration, Center for Drug Evaluation and ResearchFederal	Mar. 24, 2020	2020 Q22020 Q32020 Q42021 Q12021 Q22021 Q3	Context (guidance or announcement)Supply chainOther	Primary source read
Ex. AGY-FED-HEALTH-OTHER-049	Emergency Use Authorization: Imported, Non-NIOSH-Approved Disposable Filtering Facepiece Respirators (issued Mar. 24, 2020; reissued Mar. 28, 2020, May 7, 2020 and Mar. 24, 2021; revoked July 6, 2021)Letter of Authorization, Imported Non-NIOSH-Approved Disposable Filtering Facepiece Respirators (reissued Mar. 24, 2021)	Denise M. Hinton, Chief Scientist, FDA	United States (federal); Food and Drug AdministrationFederal	Mar. 24, 2021	2020 Q22020 Q32020 Q42021 Q12021 Q22021 Q3	Health care ordersSupply chain	Primary source read
Ex. AGY-FED-HEALTH-OTHER-051	Emergency Use Authorization: Ventilators, anesthesia gas machines modified for use as ventilators, positive pressure breathing devices modified for use as ventilators, ventilator tubing connectors and ventilator accessories (Mar. 24, 2020)Letter of Authorization to Manufacturers and Other Stakeholders: Ventilators	Denise M. Hinton, Chief Scientist, FDA	United States (federal); Food and Drug AdministrationFederal	Mar. 24, 2020	2020 Q22020 Q32020 Q42021 Q12021 Q22021 Q3	Health care ordersSupply chain	Primary source read
Ex. AGY-FED-HEALTH-OTHER-044	Guidance: Enforcement Policy for Face Masks and Respirators During the Coronavirus Disease (COVID-19) Public Health Emergency (Mar. 25, 2020; revised Apr. 2020, May 2020, Sept. 2021; superseded Sept. 5, 2023)Enforcement Policy for Face Masks and Respirators During the Coronavirus Disease (COVID-19) Public Health Emergency	Food and Drug Administration, CDRH	United States (federal); Food and Drug Administration, Center for Devices and Radiological HealthFederal	Mar. 25, 2020	2020 Q22020 Q32020 Q42021 Q12021 Q22021 Q3	Context (guidance or announcement)Face-covering requirementSupply chainOther	Confirmed from a secondary source
Ex. AGY-FED-HEALTH-OTHER-045	Guidance for Industry: Temporary Policy Regarding Nutrition Labeling of Certain Packaged Food During the COVID-19 Public Health Emergency (Mar. 26, 2020)Temporary Policy Regarding Nutrition Labeling of Certain Packaged Food During the COVID-19 Public Health Emergency	Food and Drug Administration, CFSAN	United States (federal); Food and Drug Administration, Center for Food Safety and Applied NutritionFederal	Mar. 26, 2020	2020 Q22020 Q32020 Q42021 Q12021 Q22021 Q3	Context (guidance or announcement)Supply chainOther	Primary source read
Ex. AGY-FED-HEALTH-OTHER-037	Emergency Use Authorization Declaration (drugs and biological products), 85 Fed. Reg. 18250 (Apr. 1, 2020)Emergency Use Authorization Declaration	Alex M. Azar II, Secretary of Health and Human Services	United States (federal); Department of Health and Human Services, Office of the SecretaryFederal	Mar. 27, 2020	2020 Q22020 Q32020 Q42021 Q12021 Q22021 Q3	Emergency declarationSupply chain	Primary source read
Ex. AGY-FED-HEALTH-OTHER-050	Emergency Use Authorization: Battelle Critical Care Decontamination System for decontaminating compatible N95 respirators (issued Mar. 28, 2020; reissued Jan. 21, 2021; revoked June 30, 2021)Letter of Authorization, Battelle CCDS Critical Care Decontamination System (reissued Jan. 21, 2021)	Denise M. Hinton, Chief Scientist, FDA (letter to Battelle Memorial Institute)	United States (federal); Food and Drug AdministrationFederal	Jan. 21, 2021	2020 Q22020 Q32020 Q42021 Q12021 Q2	Health care ordersSupply chain	Primary source read
Ex. AGY-FED-HEALTH-OTHER-073	COVID-19 Action Plan: Phase Five (ordered Mar. 31, 2020; effective Apr. 1, 2020): inmates secured in assigned cells/quarters for 14 days; quarantine of new admissionsCOVID-19 Action Plan: Phase Five - Additional Agency-wide Actions Effective April 1	Director, Federal Bureau of Prisons	United States (federal); Federal Bureau of PrisonsFederal	Mar. 31, 2020	2020 Q2	Business closureGathering capQuarantine and isolation	Primary source read
Ex. AGY-FED-HEALTH-OTHER-053	Emergency Use Authorization: Face Shields (umbrella) (issued Apr. 9, 2020; amended Apr. 13, 2020)Letter of Authorization, Face Shields (Apr. 13, 2020)	Denise M. Hinton, Chief Scientist, FDA	United States (federal); Food and Drug AdministrationFederal	Apr. 13, 2020	2020 Q22020 Q32020 Q42021 Q12021 Q22021 Q3	Health care ordersSupply chain	Primary source read
Ex. AGY-FED-HEALTH-OTHER-017	DEA-DC-027 (DEA083), letter to DEA-registered distributors and manufacturers granting an exception to the signed-delivery requirement for narcotic shipments to narcotic treatment programsDEA Dist/MNF narcotics shipments to OTP signed delivery exception (final)	William T. McDermott, Assistant Administrator, Diversion Control Division, DEA	United States (federal); Drug Enforcement Administration, Diversion Control DivisionFederal	Apr. 10, 2020	2020 Q22020 Q32020 Q42021 Q12021 Q22021 Q3	Supply chainOther	Primary source read
Ex. AGY-FED-HEALTH-OTHER-019	DEA-DC-029 (DEA085), letter granting a temporary exception to the five percent rule for practitioners distributing controlled substances to other registrants during the COVID-19 emergencyDEA 5 percent practitioner exception (final)	William T. McDermott, Assistant Administrator, Diversion Control Division, DEA	United States (federal); Drug Enforcement Administration, Diversion Control DivisionFederal	Apr. 13, 2020	2020 Q22020 Q32020 Q42021 Q12021 Q22021 Q3	Health care ordersSupply chainOther	Primary source read
Ex. AGY-FED-HEALTH-OTHER-033	Notice, Guidance Documents Related to Coronavirus Disease 2019 (COVID-19); Availability, 85 Fed. Reg. 27987 (May 12, 2020)Guidance Documents Related to Coronavirus Disease 2019 (COVID-19); Availability	Food and Drug Administration, HHS	United States (federal); Food and Drug AdministrationFederal	May 12, 2020	2020 Q22020 Q32020 Q42021 Q12021 Q22021 Q3	Health care ordersSupply chainOther	Primary source read
Ex. AGY-FED-HEALTH-OTHER-077	COVID-19 Action Plan: Phase Seven (ordered May 18, 2020): all Phase Six measures extended through June 30, 2020COVID-19 Action Plan: Phase Seven - Agency-wide measures extended	Director, Federal Bureau of Prisons	United States (federal); Federal Bureau of PrisonsFederal	May 20, 2020	2020 Q2	Business closureGathering capTravel and quarantineQuarantine and isolation	Primary source read
Ex. AGY-FED-HEALTH-OTHER-054	Emergency Use Authorization: Gowns and Other Apparel (umbrella) (May 22, 2020)Letter of Authorization, Gowns and Other Apparel	Denise M. Hinton, Chief Scientist, FDA	United States (federal); Food and Drug AdministrationFederal	May 22, 2020	2020 Q22020 Q32020 Q42021 Q12021 Q22021 Q3	Health care ordersSupply chain	Primary source read
Ex. AGY-FED-HEALTH-OTHER-034	Notice, Authorization of Emergency Use of Certain Medical Devices During COVID-19; Availability, 85 Fed. Reg. 34638 (June 5, 2020)Authorization of Emergency Use of Certain Medical Devices During COVID-19; Availability	Food and Drug Administration, HHS	United States (federal); Food and Drug AdministrationFederal	June 5, 2020	2020 Q22020 Q32020 Q42021 Q12021 Q22021 Q3	Health care ordersSupply chain	Primary source read
Ex. AGY-FED-HEALTH-OTHER-055	Emergency Use Authorization: Surgical Masks (umbrella) (issued Aug. 5, 2020; reissued Mar. 6, 2023)Letter of Authorization, Surgical Masks (reissued Mar. 6, 2023)	Food and Drug Administration (Office of the Chief Scientist)	United States (federal); Food and Drug AdministrationFederal	Mar. 6, 2023	2020 Q32020 Q42021 Q12021 Q22021 Q3	Health care ordersSupply chain	Primary source read

Alex M. Azar II, Secretary of Health and Human Services, Determination of Public Health Emergency and Declaration that circumstances exist justifying emergency use of in vitro diagnostics, 85 Fed. Reg. 7316 (Feb. 7, 2020) (Feb. 4, 2020) (Ex. AGY-FED-HEALTH-OTHER-038)
Alex M. Azar II, Secretary of Health and Human Services, Emergency Use Declaration (personal respiratory protective devices), 85 Fed. Reg. 13907 (Mar. 10, 2020) (Mar. 2, 2020) (Ex. AGY-FED-HEALTH-OTHER-039)
Jacqueline A. O'Shaughnessy, Acting Chief Scientist, FDA (letter to CDC), Emergency Use Authorization: NIOSH-approved air purifying respirators for health care personnel (issued Mar. 2, 2020; reissued Mar. 28, 2020 and July 12, 2021) (Ex. AGY-FED-HEALTH-OTHER-052)
Federal Bureau of Prisons (Director), after coordination with DOJ and the White House, Federal Bureau of Prisons COVID-19 Action Plan, Phase Two: agency-wide modified operations (Mar. 13, 2020) (Ex. AGY-FED-HEALTH-OTHER-072)
Social Security Administration (Andrew Saul, Commissioner; press release by Mark Hinkle, Acting Press Officer), Press release of Mar. 16, 2020: 'Effective March 17, 2020, Social Security Offices Will Only Offer Phone Service' (Ex. AGY-FED-HEALTH-OTHER-086)
Food and Drug Administration, CDER, Guidance for Industry: Temporary Policy for Preparation of Certain Alcohol-Based Hand Sanitizer Products During the Public Health Emergency (COVID-19) (Mar. 19, 2020; updated Mar. 27 and Apr. 15, 2020, and later) (Ex. AGY-FED-HEALTH-OTHER-041)
Thomas W. Prevoznik, Deputy Assistant Administrator, Diversion Control Division, DEA (letter to the Healthcare Distribution Alliance), DEA-DC-019 (DEA066), letter granting an exception permitting transmission of DEA Form 222 by fax or scan during the COVID-19 emergency (Mar. 20, 2020) (Ex. AGY-FED-HEALTH-OTHER-012)
Food and Drug Administration, CDRH, Guidance for Industry and FDA Staff: Enforcement Policy for Ventilators and Accessories and Other Respiratory Devices During the Coronavirus Disease 2019 (COVID-19) Public Health Emergency (March 2020) (Mar. 22, 2020) (Ex. AGY-FED-HEALTH-OTHER-043)
Alex M. Azar II, Secretary of Health and Human Services, Emergency Use Authorization Declaration (medical devices, including alternative products used as medical devices), 85 Fed. Reg. 17335 (Mar. 27, 2020) (Mar. 24, 2020) (Ex. AGY-FED-HEALTH-OTHER-036)
Food and Drug Administration, CDER, Guidance for Industry: Temporary Policy for Manufacture of Alcohol for Incorporation Into Alcohol-Based Hand Sanitizer Products During the Public Health Emergency (COVID-19) (Mar. 24, 2020; updated Mar. 27 and Apr. 15, 2020, and later) (Ex. AGY-FED-HEALTH-OTHER-042)
Denise M. Hinton, Chief Scientist, FDA, Emergency Use Authorization: Imported, Non-NIOSH-Approved Disposable Filtering Facepiece Respirators (issued Mar. 24, 2020; reissued Mar. 28, 2020, May 7, 2020 and Mar. 24, 2021; revoked July 6, 2021) (Ex. AGY-FED-HEALTH-OTHER-049)
Denise M. Hinton, Chief Scientist, FDA, Emergency Use Authorization: Ventilators, anesthesia gas machines modified for use as ventilators, positive pressure breathing devices modified for use as ventilators, ventilator tubing connectors and ventilator accessories (Mar. 24, 2020) (Ex. AGY-FED-HEALTH-OTHER-051)
Food and Drug Administration, CDRH, Guidance: Enforcement Policy for Face Masks and Respirators During the Coronavirus Disease (COVID-19) Public Health Emergency (Mar. 25, 2020; revised Apr. 2020, May 2020, Sept. 2021; superseded Sept. 5, 2023) (Ex. AGY-FED-HEALTH-OTHER-044)
Food and Drug Administration, CFSAN, Guidance for Industry: Temporary Policy Regarding Nutrition Labeling of Certain Packaged Food During the COVID-19 Public Health Emergency (Mar. 26, 2020) (Ex. AGY-FED-HEALTH-OTHER-045)
Alex M. Azar II, Secretary of Health and Human Services, Emergency Use Authorization Declaration (drugs and biological products), 85 Fed. Reg. 18250 (Apr. 1, 2020) (Mar. 27, 2020) (Ex. AGY-FED-HEALTH-OTHER-037)
Denise M. Hinton, Chief Scientist, FDA (letter to Battelle Memorial Institute), Emergency Use Authorization: Battelle Critical Care Decontamination System for decontaminating compatible N95 respirators (issued Mar. 28, 2020; reissued Jan. 21, 2021; revoked June 30, 2021) (Ex. AGY-FED-HEALTH-OTHER-050)
Director, Federal Bureau of Prisons, COVID-19 Action Plan: Phase Five (ordered Mar. 31, 2020; effective Apr. 1, 2020): inmates secured in assigned cells/quarters for 14 days; quarantine of new admissions (Ex. AGY-FED-HEALTH-OTHER-073)
Denise M. Hinton, Chief Scientist, FDA, Emergency Use Authorization: Face Shields (umbrella) (issued Apr. 9, 2020; amended Apr. 13, 2020) (Ex. AGY-FED-HEALTH-OTHER-053)
William T. McDermott, Assistant Administrator, Diversion Control Division, DEA, DEA-DC-027 (DEA083), letter to DEA-registered distributors and manufacturers granting an exception to the signed-delivery requirement for narcotic shipments to narcotic treatment programs (Apr. 10, 2020) (Ex. AGY-FED-HEALTH-OTHER-017)
William T. McDermott, Assistant Administrator, Diversion Control Division, DEA, DEA-DC-029 (DEA085), letter granting a temporary exception to the five percent rule for practitioners distributing controlled substances to other registrants during the COVID-19 emergency (Apr. 13, 2020) (Ex. AGY-FED-HEALTH-OTHER-019)
Food and Drug Administration, HHS, Notice, Guidance Documents Related to Coronavirus Disease 2019 (COVID-19); Availability, 85 Fed. Reg. 27987 (May 12, 2020) (Ex. AGY-FED-HEALTH-OTHER-033)
Director, Federal Bureau of Prisons, COVID-19 Action Plan: Phase Seven (ordered May 18, 2020): all Phase Six measures extended through June 30, 2020 (May 20, 2020) (Ex. AGY-FED-HEALTH-OTHER-077)
Denise M. Hinton, Chief Scientist, FDA, Emergency Use Authorization: Gowns and Other Apparel (umbrella) (May 22, 2020) (Ex. AGY-FED-HEALTH-OTHER-054)
Food and Drug Administration, HHS, Notice, Authorization of Emergency Use of Certain Medical Devices During COVID-19; Availability, 85 Fed. Reg. 34638 (June 5, 2020) (Ex. AGY-FED-HEALTH-OTHER-034)
Food and Drug Administration (Office of the Chief Scientist), Emergency Use Authorization: Surgical Masks (umbrella) (issued Aug. 5, 2020; reissued Mar. 6, 2023) (Ex. AGY-FED-HEALTH-OTHER-055)

The Orders Library

Results